Joseph Kim
@JMKimMD
Followers
253
Following
800
Media
7
Statuses
93
Cardiology Fellow @BIDMCCVI and @SmithBIDMC by way of @BrighamMedRes
Joined June 2022
RT @lucas_marinacci: Thank you @MyJSCAI for the opportunity to discuss our review on the evolving role of transcatheter aspiration for endo….
0
7
0
RT @BIDMCVFellows: Just spotted: four T32 fellows learning about poisson regression for their @HarvardChanSPH Masters! .
0
3
0
A privilege to represent @SmithBIDMC in presenting our work on the final analysis of SAFE-PAD at #ACC25! A monumental effort by @EricSecemskyMD, @rwyeh and team to show the safety of peripheral drug-coated devices. Great company, great food, great times!
0
6
24
A privilege to cover a critical and impactful study by the great @BradleyPetek!.
Survival After Sudden Cardiac Arrest Improves in Young Athletes, but Racial Disparities Persist. Written by @JMKimMD! . Summary, analysis and more #ACC25 coverage below! . @CMichaelGibson @ceciliabahit.
0
0
5
RT @SmithBIDMC: Congrats to Sarnoff Fellow @frank_medina_ on his induction to the Gold Humanism Honor Society, recognizing medical students….
0
3
0
Thank you🙏to @JACCJournals for highlighting our work on the effect of contemporary events on femoropopliteal revascularizations among Medicare beneficiaries!. Only possible thanks to the leadership of @EricSecemskyMD, @rwyeh and others @SmithBIDMC!.
Fem-pop revascularizations: Undergoing a substantial decline? See the trends: #JACC #Revascularization #Revasc @rwyeh @JMKimMD
1
4
14
RT @CN_publishing: Study finds adverse outcomes after decreased use of #paclitaxel-coated devices @EricSecemskyMD
cardiovascularnews.com
A recent analysis of over 270,000 Medicare fee-for-service beneficiaries has found an increase in adverse outcomes and death after a US FDA warning led to decreased use of paclitaxel-coated devices...
0
2
0
To kick off the new year, @EricSecemskyMD and I discuss the APEX-AV trial and the newly approved AlphaVac device for PE mechanical thrombectomy in @MyJSCAI. 2025 will be a great year for PE therapies, with lots of trials in the pipeline!.
2
4
19
RT @CardioBusiness: Momentary concerns over paclitaxel-coated devices may have put PAD patients at risk @SCAI @JACCjournals @ACCinTouch @AC….
cardiovascularbusiness.com
Back in 2019, the FDA issued a warning about the use of paclitaxel-coated devices when treating peripheral artery disease. The agency took back that warning in 2023, but it appears to have made a...
0
2
0
Excited to share our study of changing practice patterns in the use of drug-coated devices in fem-pop revascularizations, now in @JACCJournals!. Grateful always to @EricSecemskyMD for his mentorship, and to @SCAI for the Early Career Research Grant supporting our work!.
Trends in fem-pop revascularization respond to pivotal events; Late 2010s paclitaxel safety concerns were associated with ⬇ drug-coated device use and ⬆ mortality, exacerbated by COVID-19. @JMKimMD @EricSecemskyMD et al in @JACCJournals:
3
4
22
Amazing work by @lucas_marinacci to highlight the challenges and need for more evidence for percutaneous options of source control in infective endocarditis. Exciting times ahead!. @BIDMCVFellows @SmithBIDMC.
Percutaneous mechanical aspiration for endocarditis may help achieve source control and reduce embolization risk -- but better evidence is needed. In this article we go through each IE subtype, discuss the available evidence, and outline the field's future.
0
0
8
Huge congratulations to our incoming F1 class!!.
We are so thrilled to welcome this truly exceptional group of cardiology fellows to Beth Israel Deaconess Medical Center!!!
0
0
36
RT @BIDMCVFellows: We are so thrilled to welcome this truly exceptional group of cardiology fellows to Beth Israel Deaconess Medical Center….
0
13
0